PortfoliosLab logo

Atea Pharmaceuticals, Inc. (AVIR)

Equity · Currency in USD · Last updated Feb 7, 2023

Company Info

ISINUS04683R1068
CUSIP04683R106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$4.55
Year Range$4.35 - $8.79
EMA (50)$4.80
EMA (200)$5.85
Average Volume$430.54K
Market Capitalization$378.96M

AVIRShare Price Chart


Loading data...

AVIRPerformance

The chart shows the growth of $10,000 invested in Atea Pharmaceuticals, Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,500 for a total return of roughly -85.00%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%OctoberNovemberDecember2023February
-38.93%
3.64%
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AVIRCompare to other instruments

Search for stocks, ETFs, and funds to compare with AVIR

Atea Pharmaceuticals, Inc.

AVIRReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-3.19%5.55%
YTD-5.41%7.07%
6M-48.24%-0.82%
1Y-33.48%-8.65%
5Y-56.84%10.67%
10Y-56.84%10.67%

AVIRMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-3.74%
2022-8.54%-24.13%5.45%-21.83%2.56%

AVIRSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Atea Pharmaceuticals, Inc. Sharpe ratio is -0.58. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20OctoberNovemberDecember2023February
-0.58
-0.34
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AVIRDividend History


Atea Pharmaceuticals, Inc. doesn't pay dividends

AVIRDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%OctoberNovemberDecember2023February
-94.86%
-14.29%
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)

AVIRWorst Drawdowns

The table below shows the maximum drawdowns of the Atea Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Atea Pharmaceuticals, Inc. is 95.08%, recorded on Dec 28, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.08%Feb 9, 2021476Dec 28, 2022
-22.86%Nov 9, 20201Nov 9, 202013Nov 27, 202014
-19.37%Nov 30, 20208Dec 9, 20208Dec 21, 202016
-7.22%Nov 2, 20202Nov 3, 20201Nov 4, 20203
-7.15%Feb 4, 20211Feb 4, 20212Feb 8, 20213
-6.4%Jan 21, 20211Jan 21, 20214Jan 27, 20215
-5.89%Jan 11, 20212Jan 12, 20211Jan 13, 20213
-4.78%Dec 23, 20202Dec 24, 20201Dec 28, 20203
-0.86%Jan 4, 20211Jan 4, 20211Jan 5, 20212

AVIRVolatility Chart

Current Atea Pharmaceuticals, Inc. volatility is 33.87%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%OctoberNovemberDecember2023February
33.87%
16.98%
AVIR (Atea Pharmaceuticals, Inc.)
Benchmark (^GSPC)